ALFA Finder| Revenue guidance | 20.0% → 5.0% Cut by 15.0 percentage points |
|---|
| Revenue growth | -42% YoY; -57% QoQ. |
|---|---|
| Margins | EBITDA margin contracted 624 bps YoY to 23.3%. |
| Order book | CRAMS pipeline on track; projects contribute from H2FY27. |
| Demand visibility | Subdued European demand persisting into Q2FY27. |
| Management confidence | Confident in H2FY27 recovery via direct sales and CRAMS. |
Growth
Revenue from operations fell 42% YoY to ₹14.36 Cr; PAT dropped 68% YoY to ₹1.12 Cr.
Outlook
Moderated FY27 non-linear growth guidance. Block 7 commissioning H1FY27; ₹15 Cr FY26 capex for R&D and expansion.
Risks
Subdued European demand; raw material volatility; termination of key EU marketing agreement leading to temporary volume loss.
Investor Presentation filed with BSE, NSE: SGRL. Summary written with AI assistance from the document.
Shree Ganesh Remedies Ltd: key numbers
- Share price
- ₹624.30
- Market cap
- ₹801.5 Cr
- Revenue (annual)
- ₹109.3 Cr
- Net profit (annual)
- ₹17.76 Cr
- P/E (TTM)
- 66.2×Sector 43.8×
- Promoter holding
- 72.84%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shree Ganesh Remedies Ltd
All →Shree Ganesh Remedies Investor Presentation: Key Takeaways
Q2FY27 revenue ₹23.29 Cr (-23% YoY, +62% QoQ), EBITDA margin 16.9%, PAT ₹1.63 Cr (-67% YoY). Sequential recovery; CRAMS and new products progressing.
Shree Ganesh Remedies Results Update
Shree Ganesh Remedies released a press release on Q2 and H1 FY27 unaudited results, with Q2 revenue of ₹23.29 Crore, down 23% year-on-year. PAT fell 67% to ₹1.63 Crore.
Shree Ganesh Remedies Q2 FY27 Results: Net Profit ₹1.6 Cr, Down 68.0% YoY
Shree Ganesh Remedies' board approved unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Revenue from operations for the half year was Rs 3,765.47 lakhs, down from Rs 5,498.29 lakhs a year earlier.
- Key figure
- Net profit ₹1.6 Cr · -68.0% YoY
Shree Ganesh Remedies Board Meeting Date
Shree Ganesh Remedies Ltd notified BSE of a board meeting on October 31, 2026, to consider unaudited standalone and consolidated results for the quarter ended September 2026. Trading window remains closed until 48 hours after the results declaration.
Shree Ganesh Remedies Other Announcement
Shree Ganesh Remedies Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Shree Ganesh Remedies Management Change
Shree Ganesh Remedies Ltd has announced the resignation of Mr. Aditya Vikrambhai Patel as Company Secretary and the appointment of Ms. Akanksha as his successor.